News

Santhera Pharmaceuticals has announced that Catena will be made available on a named patient basis in Europe. Santhera’s Named Patient Program (NPP) allows healthcare professionals to prescribe the

Cordis has announced that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery

Huntsman has signed a “stalking horse” asset and equity purchase agreement pursuant to which its wholly-owned subsidiary Huntsman Pigments has agreed to acquire the following assets of Tronox

Abbott has announced at the European Society of Cardiology Congress the availability of its XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

Roche has announced that the FDA has approved Valcyte (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to

Roche and Lonza have announced that Genentech Singapore, a wholly-owned member of the Roche Group, elected to exercise an option to purchase from Lonza its cell culture biologic

Ashland has completed the sale of its global marine services business, Drew Marine, to JF Lehman & Co. for approximately $120m before tax. Ashland will use the net

Clariant has sold its specialty silicones business, including its Gainesville Florida facility, to SiVance, an affiliate of New York-based GenNx360 Capital Partners. GenNx360 is a private equity firm

Sinovac has reported that Sinovac’s H1N1 vaccine has passed the experts evaluation by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production license